Registry Data Instead Of Randomized Control May Accelerate HF Device Trials
This article was originally published in The Gray Sheet
Executive Summary
Large heart failure registries will provide data that could be used in lieu of a randomized control in trials of new heart failure devices, according to participants at the annual Transcathether Cardiovascular Therapeutics HHS "Town Hall Meeting" Oct. 19